These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 840828)

  • 21. [Long-term treatment of chronic rheumatoid arthritis with D-penicillamin (author's transl)].
    Tausch G; Bröll H; Eberl R
    Schweiz Rundsch Med Prax; 1977 Nov; 66(45):1427-30. PubMed ID: 412181
    [No Abstract]   [Full Text] [Related]  

  • 22. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
    Hoshi K; Mizushima Y
    Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of malignant rheumatoid arthritis associated with myasthenia gravis by D-penicillamine treatment (author's transl)].
    Suzuki H; Imai H; Shiokawa Y
    Ryumachi; 1980 Jun; 20(3):163-70. PubMed ID: 7414431
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [D-penicillamine in rheumatoid arthritis : hematological incidents and accidents (author's transl)].
    Franck JL; Bouteiller G; Gayrard M; Arlet J
    Sem Hop; 1979 Sep 8-15; 55(27-30):1325-7. PubMed ID: 228408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The serum copper level and the therapeutic effect of D-penicylamine in patients with rheumatoid arthritis (author's transl)].
    Rudy J; Sarosiek J; Borejszo I
    Przegl Lek; 1978; 35(12):879-83. PubMed ID: 734155
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test].
    Shiokawa Y; Horiuchi T; Honma M; Kageyama T; Okada T
    Ryumachi; 1977 Mar; 17(2):205-10. PubMed ID: 325668
    [No Abstract]   [Full Text] [Related]  

  • 31. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Review of 36 cases of rheumatoid arthritis treated with penicillamine D].
    García López A; Peña Arrébola A
    Rev Esp Reum Enferm Osteoartic; 1977; 20(1):9-44. PubMed ID: 323940
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiences in the treatment of chronic polyarthritis using D-penicillamine (proceedings)].
    Dürrigl T; Pucar I
    Z Rheumatol; 1976; 35 Suppl 4():suppl 464-9. PubMed ID: 983407
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1976 Jun; 3(2):145-54. PubMed ID: 950631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prolonged neuromuscular blockade during a D. penicillamine-induced myasthenia (author's transl)].
    Blanloeil Y; Baron D; Gazeau MF; Nicolas F
    Anesth Analg (Paris); 1980; 37(7-8):441-3. PubMed ID: 7425327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [D-penicillamine in the treatment of rheumatoid arthritis].
    Gerloni V; Colombo B; Carraière G
    Reumatismo; 1977; 29(2-3):157-62. PubMed ID: 616962
    [No Abstract]   [Full Text] [Related]  

  • 38. [D-penicillamine in the treatment of rheumatoid polyarthritis].
    Santamaria A; Barcelo P; Menchon M; Ripoll M; Ruiz de la Torre R
    Rev Esp Reum Enferm Osteoartic; 1976; 19(2):133-79. PubMed ID: 785553
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of Cuprenil (D-penicillamine) treatment in patients with rheumatoid arthritis].
    Maldykowa H; Chwalińska-Sadowska H; Luft S; Glińska-Urban D; Mikolajew M; Odrzywolska A; Jaworska H
    Reumatologia; 1972; 10(1):9-21. PubMed ID: 5019762
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.